111 related articles for article (PubMed ID: 2453419)
1. Study on a new chromogenic substrate for the prothrombin time determination.
Girolami A; Santarossa A; Martinelli S; Sartori MT; Visentin I
Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(6):881-95. PubMed ID: 2453419
[TBL] [Abstract][Full Text] [Related]
2. Multicenter evaluation of a chromogenic substrate method for photometric determination of prothrombin time.
Dati F; Barthels M; Conard J; Flückiger J; Girolami A; Hänseler E; Huber J; Keller F; Kolde HJ; Müller-Berghaus G
Thromb Haemost; 1987 Oct; 58(3):856-65. PubMed ID: 3433249
[TBL] [Abstract][Full Text] [Related]
3. [Methodological aspects of the photometric determination of prothrombin time using chromogenic substrates].
Dati F; Kolde HJ; Heimburger N; Keller F
J Clin Chem Clin Biochem; 1986 Nov; 24(11):877-88. PubMed ID: 3806016
[TBL] [Abstract][Full Text] [Related]
4. [Determination of thromboplastin time with a new standardized thromboplastin from human placenta: results of a cooperative study].
Barthels M; Bruhn HD; Duckert F; Meyer JG; Dati F; Fuhge P
J Clin Chem Clin Biochem; 1987 Apr; 25(4):267-80. PubMed ID: 3625130
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a new chromogenic substrate assay for the measurement of the prothrombin time.
van Wersch JW
Scand J Clin Lab Invest; 1993 Oct; 53(6):563-8. PubMed ID: 8266001
[TBL] [Abstract][Full Text] [Related]
6. Chromogenic substrate (S-2222) factor X assays in the follow-up of coumarin treated patients. No advantage over prothrombin time and/or thrombotest.
Girolami A; Saggin L; Gazzetta R; Saltarin P
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(4):610-6. PubMed ID: 6170557
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of Quick/INR values of whole capillary blood (CoaguChek Plus) and venous citrate plasma in patients with and without oral anticoagulation].
Burri S; Demarmels Biasiutti F; Lämmle B; Wuillemin WA
Schweiz Med Wochenschr; 1998 Oct; 128(44):1723-9. PubMed ID: 9846345
[TBL] [Abstract][Full Text] [Related]
8. [Prothrombin time and its standardization].
Kagawa K
Rinsho Byori; 2002 Aug; 50(8):779-85. PubMed ID: 12373814
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of a new chromogenic method for measuring prothrombin time in the control of oral anticoagulant therapy].
Colla G; Corciulo G
Boll Soc Ital Biol Sper; 1984 Nov; 60(11):2025-31. PubMed ID: 6525255
[TBL] [Abstract][Full Text] [Related]
10. [Simultaneous determination of zymogen activation time and zymogen level using chromogenic substrates in blood coagulation analysis].
Svendsen L; Brogli M; Stocker K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):150-6. PubMed ID: 6177596
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of a sensitive rabbit brain thromboplastin and a human placenta thromboplastin for thromboplastin time determination].
Lämmle B; Furlan M; Sulzer I
Schweiz Med Wochenschr; 1989 Feb; 119(6):178-83. PubMed ID: 2928740
[TBL] [Abstract][Full Text] [Related]
12. Prothrombin determination by means of a chromogenic peptide substrate.
Axelsson G; Korsan-Bengtsen K; Waldenström J
Thromb Haemost; 1976 Dec; 36(3):517-24. PubMed ID: 65799
[TBL] [Abstract][Full Text] [Related]
13. [Comparative multicenter study of a rabbit high-sensitivity thromboplastin and a recombinant thromboplastin with synthetic phospholipids].
Martínez-Brotóns F; Borrell M; Fontcuberta J; Batlle J; López F; Páramo JA; Ribera C; Rocha E; Vicente V; Zuazu I
Sangre (Barc); 1994 Aug; 39(4):245-51. PubMed ID: 7985052
[TBL] [Abstract][Full Text] [Related]
14. Taipan viper venom and chromogenic substrate (chromozym Th). Prothrombin assay. No sensitivity to coumarin-induced prothrombin.
Girolami A; Petrassi G; Cella G; Saltarin P
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):822-30. PubMed ID: 6176507
[TBL] [Abstract][Full Text] [Related]
15. Multicentric evaluation of a new PT reagent based on recombinant human tissue factor and synthetic phospholipids.
Bader R; Mannucci PM; Tripodi A; Hirsh J; Keller F; Solleder EM; Hawkins P; Peng M; Pelzer H; Teijidor LM
Thromb Haemost; 1994 Mar; 71(3):292-9. PubMed ID: 8029792
[TBL] [Abstract][Full Text] [Related]
16. Experience with chromogenic substrates in studies of clotting and fibrinolytic systems.
Chmielewska J; Latallo ZS
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):111-4. PubMed ID: 6177591
[TBL] [Abstract][Full Text] [Related]
17. A chromogenic assay of prothrombin compared with coagulation tests during anticoagulant therapy and liver disease.
Tripodi A; Di Santo C; Mannucci PM
Ric Clin Lab; 1981; 11(3):215-22. PubMed ID: 7291868
[TBL] [Abstract][Full Text] [Related]
18. Monitoring of heparin therapy with the activated partial thromboplastin time and chromogenic substrate assays.
Fey MF; Lang M; Furlan M; Beck EA
Thromb Haemost; 1987 Oct; 58(3):853-5. PubMed ID: 3481140
[TBL] [Abstract][Full Text] [Related]
19. Monitoring oral anticoagulant treatment from plasma stored for up to 48 hours and frozen plasma.
Grau E; Tenias JM; Olaso MA; Ferrando I; Juan MT; Pastor E; Perez A; Real E
Haematologica; 1999 Jul; 84(7):633-6. PubMed ID: 10406906
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.
Gessoni G; Valverde S
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):603-10. PubMed ID: 17890946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
